In in vivo experiments, SLT treatments significantly elevated the function of Nrf2 in the brain infarction; accordingly, the expression of HO-1, activity of SOD, and content of GSH in the brain were all increased by SLT, indicating the downstreams of Nrf2 were activated. Here, SOD1 is linked to brain infarction.